Rankings
▼
Calendar
CGEN
Compugen Ltd.
$202M
Q3 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$17M
Gross Profit
$14M
79.0% margin
Operating Income
$4M
26.2% margin
Net Income
$1M
7.4% margin
EPS (Diluted)
$0.01
QoQ Revenue Growth
+155.6%
Balance Sheet
Total Assets
$124M
Total Liabilities
$63M
Stockholders' Equity
$60M
Cash & Equivalents
$7M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$17M
$0
—
Gross Profit
$14M
$0
—
Operating Income
$4M
-$11M
+142.3%
Net Income
$1M
-$10M
+113.0%
← FY 2024
All Quarters
Q4 2024 →
CGEN Q3 2024 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena